Ilana Löwy is with the Centre de Recherche Médicine, Science, Santé et Societé- CERMES 3 (Institut national de la santé et de la recherche médicale, Centre national de la recherche scientifique, École des hautes études en sciences sociales, Paris V), Paris, France. Marilena Cordeiro Dias Villela Corrêa is with the Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Am J Public Health. 2020 May;110(5):677-684. doi: 10.2105/AJPH.2019.305562. Epub 2020 Mar 19.
In the aftermath of the introduction of severe restrictions on abortion in several US states, some activists have argued that providing widespread access to an abortive drug, misoprostol, will transform an induced abortion into a fully private act and therefore will empower women. In Brazil, where abortion is criminalized, the majority of women who wish to terminate an unwanted pregnancy already use the illegal, but easily accessible, misoprostol. We examine the history of misoprostol as an abortifacient in Brazil from the late 1980s until today and the professional debates on the teratogenicity of this drug. The effects of a given pharmaceutical compound, we argue, are always articulated, elicited, and informed within dense networks of sociocultural, economic, legal, and political settings. In a conservative and repressive environment, the use of misoprostol for self-induced abortions, even when supported by formal or informal solidarity networks, is far from being a satisfactory solution to the curbing of women's reproductive rights.
在美国多个州对堕胎实施严格限制后,一些活动人士认为,广泛提供堕胎药物米索前列醇将使人工流产成为完全私人的行为,从而赋予妇女权力。在巴西,堕胎是犯罪行为,大多数希望终止意外怀孕的妇女已经在使用非法但容易获得的米索前列醇。我们考察了米索前列醇作为堕胎药在巴西从 20 世纪 80 年代末至今的历史,以及对这种药物致畸性的专业辩论。我们认为,特定药物化合物的影响总是在社会文化、经济、法律和政治环境的密集网络中得到表达、引发和说明。在保守和压抑的环境中,即使有正式或非正式的团结网络的支持,米索前列醇用于自我诱导的堕胎,远非限制妇女生殖权利的令人满意的解决方案。